Global Mammography Vendor Profiles and Growth Opportunities Updated Research Available
Transformational Growth Driven by Disruptive AI Solutions Enhancing Workflow Efficiency and Clinical Decision-Making
20-Jul-2022
Europe
Market Research
PD24-01-00-00-00
HC03565-GL-MR_26721
This Frost & Sullivan study examines the role of artificial intelligence (AI) in the global mammography market. The high prevalence of breast cancer in women has increased the demand for breast cancer screening, which, in turn, heightened the focus on using AI-based solutions for mammography. AI solutions can reduce results variability among radiologists and improve breast cancer detection rates. They also play a pivotal role in decreasing radiologists’ workloads and boosting the affordability and accuracy of breast cancer screening programs.
The study outlines the key trends emerging in the AI and mammography space and profiles notable providers and solutions in three core mammography functions: Image analysis, triage, and clinical decision support. The study also guides technology vendors in charting their strategic priorities and building new capabilities to capitalize on emerging growth opportunities in the mammography space.
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Mammography Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Need for Routine Mammography
Pivotal Role of AI
Segmentation
Growth Drivers
Growth Restraints
Business Models for AI Solutions
Adoption Curve of AI Solutions by Function
AI Best Practices and Ethical Uses
Competitive Landscape: Regional Snapshot
Competitive Landscape: Key Vendors
Competitive Landscape: Key Vendors (continued)
Competitive Landscape: Key Vendors (continued)
Vendor Spotlight: Hologic’s Genius AI™
Vendor Spotlight: Hologic’s Genius AI™ (continued)
Vendor Spotlight: iCAD’s Profound AI®
Vendor Spotlight: iCAD’s Profound AI® (continued)
Vendor Spotlight: Lunit’s INSIGHT
Vendor Spotlight: Lunit’s INSIGHT (continued)
Vendor Spotlight: Densitas’s intelliMammo®
Vendor Spotlight: Densitas’s intelliMammo® (continued)
Vendor Spotlight: RadNet’s Saige-Q
Vendor Spotlight: RadNet’s Saige-Q (continued)
Vendor Spotlight: Kheiron’s Mia®
Vendor Spotlight: Kheiron’s Mia® (continued)
Vendor Spotlight: ScreenPoint Medical’s Transpara®
Vendor Spotlight: ScreenPoint Medical’s Transpara® (continued)
Vendor Spotlight: Therapixel’s MammoScreen™
Vendor Spotlight: Therapixel’s MammoScreen™ (continued)
Vendor Spotlight: Volpara Health’s Volpara Analytics™
Vendor Spotlight: Volpara Health’s Volpara Analytics™ (continued)
Vendor Spotlight: Whiterabbit.ai’s WRDensity and WRRisk
Vendor Spotlight: Whiterabbit.ai’s WRDensity and WRRisk (continued)
Vendor Spotlight: CureMetrix’s cmTriage™
Vendor Spotlight: CureMetrix’s cmTriage™ (continued)
Vendor Spotlight: Siemens Healthineers’s syngo.Breast Care
Vendor Spotlight: Siemens Healthineers’s syngo.Breast Care (continued)
Growth Opportunity 1: AI Solutions in Population-based Mammography Programs to Decrease Radiologist Burnout and Improve Clinical Outcomes
Growth Opportunity 1: AI Solutions in Population-based Mammography Programs to Decrease Radiologist Burnout and Improve Clinical Outcomes (continued)
Growth Opportunity 2: Integrating AI-based solutions with Cloud-based Platforms to Manage Large Amounts of Breast Cancer Data
Growth Opportunity 2: Integrating AI-based solutions with Cloud-based Platforms to Manage Large Amounts of Breast Cancer Data (continued)
Growth Opportunity 3: AI Cybersecurity Solutions to Secure the Infrastructure of Breast Imaging Facilities
Growth Opportunity 3: AI Cybersecurity Solutions to Secure the Infrastructure of Breast Imaging Facilities (continued)
List of Exhibits
Legal Disclaimer
- Mammography: Growth Drivers, Global, 2022–2027
- Mammography: Growth Restraints, Global, 2022–2027
- Mammography: Business Models, US and Europe, 2022
- Mammography: Adoption Curve of AI Solutions by Function, US and Europe, 2022
- Mammography: Key Manufacturers by Region, Global, 2022
- Mammography: Key Vendors, Global, 2022
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
19 Nov 2026 | Global | Technology Research
Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms
Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.